Long‐term follow‐up of patients undergoing percutaneous suprapubic tube drainage after robot‐assisted radical prostatectomy (RARP)

Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? •  Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization o...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 110; no. 4; pp. 580 - 585
Main Authors Sammon, Jesse D., Trinh, Quoc‐Dien, Sukumar, Shyam, Diaz, Mireya, Simone, Andrea, Kaul, Sanjeev, Menon, Mani
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2012
Wiley-Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1464-4096
1464-410X
1464-410X
DOI10.1111/j.1464-410X.2011.10786.x

Cover

Loading…
Abstract Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? •  Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization of anti‐cholinergic medication. •  This study demonstrates the long‐term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured. OBJECTIVES •  To evaluate the long‐term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot‐assisted radical prostatectomy (RARP). PATIENTS AND METHODS •  Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1‐year follow‐up for urinary function. •  Functional outcomes were obtained via patient‐administered questionnaire. •  Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records. RESULTS •  Urinary function assessed by patient‐administered questionnaire was analysed at a mean (sd) follow‐up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. •  In all, 86 patients (25.4%) never wore a pad; the median time to 0–1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). •  The mean (sd) follow‐up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure‐specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. •  In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven). CONCLUSIONS •  PST placement after RARP is safe and efficacious on long‐term follow‐up. •  Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.
AbstractList Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured. • To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP). • Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records. • Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven). • PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.
Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.UNLABELLEDStudy Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.• To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP).OBJECTIVES• To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP).• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.PATIENTS AND METHODS• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.• Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).RESULTS• Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).• PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.CONCLUSIONS• PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? •  Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short‐term safety, while decreasing patient discomfort and utilization of anti‐cholinergic medication. •  This study demonstrates the long‐term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured. OBJECTIVES •  To evaluate the long‐term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot‐assisted radical prostatectomy (RARP). PATIENTS AND METHODS •  Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1‐year follow‐up for urinary function. •  Functional outcomes were obtained via patient‐administered questionnaire. •  Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records. RESULTS •  Urinary function assessed by patient‐administered questionnaire was analysed at a mean (sd) follow‐up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. •  In all, 86 patients (25.4%) never wore a pad; the median time to 0–1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). •  The mean (sd) follow‐up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure‐specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. •  In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven). CONCLUSIONS •  PST placement after RARP is safe and efficacious on long‐term follow‐up. •  Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.
Study Type - Therapy (case series) Level of Evidence4 What's known on the subject? and What does the study add? * Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. * This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured. OBJECTIVES * To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP). PATIENTS AND METHODS * Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. * Functional outcomes were obtained via patient-administered questionnaire. * Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records. RESULTS * Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. * In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). * The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. * In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven). CONCLUSIONS * PST placement after RARP is safe and efficacious on long-term follow-up. * Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved. [PUBLICATION ABSTRACT]
Author Diaz, Mireya
Sukumar, Shyam
Trinh, Quoc‐Dien
Kaul, Sanjeev
Sammon, Jesse D.
Simone, Andrea
Menon, Mani
Author_xml – sequence: 1
  givenname: Jesse D.
  surname: Sammon
  fullname: Sammon, Jesse D.
– sequence: 2
  givenname: Quoc‐Dien
  surname: Trinh
  fullname: Trinh, Quoc‐Dien
– sequence: 3
  givenname: Shyam
  surname: Sukumar
  fullname: Sukumar, Shyam
– sequence: 4
  givenname: Mireya
  surname: Diaz
  fullname: Diaz, Mireya
– sequence: 5
  givenname: Andrea
  surname: Simone
  fullname: Simone, Andrea
– sequence: 6
  givenname: Sanjeev
  surname: Kaul
  fullname: Kaul, Sanjeev
– sequence: 7
  givenname: Mani
  surname: Menon
  fullname: Menon, Mani
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26234557$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22177263$$D View this record in MEDLINE/PubMed
BookMark eNqNkcuKFDEYhYOMOBd9BQmIMC66TCqpqtRGGAevNCiDA-5CKpcmTVVS5sJM71y69Bl9EtPT3Qqzmmxy-3Ly_-ecgiPnnQYAYlThMl6vK0xbuqAYfa9qhHGFUcfa6vYROPl3cXRYo749BqcxrhEqB23zBBzXNe66uiUn4NfSu9Wfn7-TDhM0fhz9TdnlGXoDZ5GsdinC7JQOK2_dCs46yJyE0z5HGPMcxJwHK2HKg4YqCOvESkNhih4MfvCpqIkYbUxawSCUlWKEc_AxiaRl8tMGnl9dXH199RQ8NmKM-tl-PgPX7999u_y4WH758OnyYrmQtGbtYqDKGCoVLs30iNGeEoUlUX2tmSaKDqwzA9KCNobUTNTFCSlboQiTtaDGkDNwvtMtRfzIOiY-2Sj1OO564hgRhBhqOlTQF_fQtc_Bleo4Jg0hTd80rFDP91QeJq34HOwkwoYfPC7Ayz0gYuneBOGkjf-5tia0abrCvdlxstgTgzZc2uKS9S4VX8dSGd-Gz9d8myvfZsy34fO78PltEWD3BA5_PODp_u8bO-rNg9_xt5-v75bkL428y3M
CODEN BJINFO
CitedBy_id crossref_primary_10_4111_icu_2016_57_2_75
crossref_primary_10_1016_j_juro_2017_11_115
crossref_primary_10_1177_2051415817706635
crossref_primary_10_1089_end_2013_1588
crossref_primary_10_1016_j_juro_2013_03_031
crossref_primary_10_1016_j_ajur_2014_09_010
crossref_primary_10_3389_fsurg_2022_944561
crossref_primary_10_1007_s11701_014_0450_7
crossref_primary_10_1007_s00345_016_1883_6
crossref_primary_10_1016_j_eururo_2017_04_029
crossref_primary_10_1111_iju_12225
crossref_primary_10_1089_end_2012_0312
crossref_primary_10_1089_end_2012_0455
crossref_primary_10_1097_GCO_0b013e3283648d12
crossref_primary_10_23736_S2724_6051_20_04146_6
crossref_primary_10_1111_iwj_14443
crossref_primary_10_1007_s11934_020_00982_3
crossref_primary_10_1038_pcan_2017_26
crossref_primary_10_1089_end_2013_0564
crossref_primary_10_1111_bju_12071
crossref_primary_10_1016_j_juro_2014_01_004
crossref_primary_10_1155_2013_902686
crossref_primary_10_1016_j_ajur_2014_09_006
crossref_primary_10_1089_end_2015_0206
crossref_primary_10_1186_s12894_017_0312_5
crossref_primary_10_1007_s00345_020_03225_9
crossref_primary_10_1016_j_asjsur_2018_08_004
crossref_primary_10_1016_j_urology_2015_02_078
Cites_doi 10.1002/bjs.5424
10.1016/S0022-5347(17)36966-5
10.1016/j.eururo.2009.01.036
10.1016/S0090-4295(00)01048-7
10.1016/j.eururo.2009.04.018
10.1016/j.eururo.2009.04.032
10.1046/j.1464-410x.2000.00670.x
10.1016/j.surg.2005.08.016
10.1097/01.ju.0000065860.16392.19
10.1038/sj.pcan.4500601
10.1016/j.eururo.2011.01.045
10.1016/S0090-4295(96)00491-8
10.1016/S0022-5347(05)67820-2
10.1016/j.eururo.2006.10.055
10.1016/S0022-5347(05)65648-0
10.1016/S0022-5347(05)67512-X
10.1097/01.ju.0000067464.53313.dd
10.1016/S0090-4295(01)01218-3
10.1016/S0090-4295(99)80237-4
10.1016/S0022-5347(17)40595-7
10.1111/j.1464-410X.2008.07875.x
10.1016/j.eururo.2009.04.019
10.1016/S0090-4295(00)00502-1
10.1038/sj.ijir.3900472
10.1016/S0022-5347(01)62202-X
ContentType Journal Article
Copyright 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
2015 INIST-CNRS
2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
Copyright_xml – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
– notice: 2015 INIST-CNRS
– notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
DOI 10.1111/j.1464-410X.2011.10786.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Calcium & Calcified Tissue Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 585
ExternalDocumentID 2975490661
22177263
26234557
10_1111_j_1464_410X_2011_10786_x
BJU10786
Genre article
Evaluation Studies
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
23N
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7X8
ID FETCH-LOGICAL-c4286-b4dff4cd10019084943d1c3d92e8e3d4b87fb0ea45f328a2410cc6ad38c2a4ff3
IEDL.DBID DR2
ISSN 1464-4096
1464-410X
IngestDate Fri Sep 05 14:39:30 EDT 2025
Sat Jul 26 02:37:29 EDT 2025
Thu Apr 03 06:58:16 EDT 2025
Mon Jul 21 09:14:30 EDT 2025
Tue Jul 01 03:49:54 EDT 2025
Thu Apr 24 23:10:32 EDT 2025
Wed Aug 20 07:24:25 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Nephrology
robotic prostatectomy
RARP
Robotics
Urology
Percutaneous route
suprapubic
PST
Treatment
Telemedicine
Follow up study
Surgery
Suprapubic drain
Prostatectomy
suprapubic tube
Language English
License CC BY 4.0
2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4286-b4dff4cd10019084943d1c3d92e8e3d4b87fb0ea45f328a2410cc6ad38c2a4ff3
Notes J.D.S. and Q.‐D.T. contributed equally.
ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 22177263
PQID 1353359558
PQPubID 1026371
PageCount 6
ParticipantIDs proquest_miscellaneous_1030080570
proquest_journals_1353359558
pubmed_primary_22177263
pascalfrancis_primary_26234557
crossref_citationtrail_10_1111_j_1464_410X_2011_10786_x
crossref_primary_10_1111_j_1464_410X_2011_10786_x
wiley_primary_10_1111_j_1464_410X_2011_10786_x_BJU10786
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2012
PublicationDateYYYYMMDD 2012-08-01
PublicationDate_xml – month: 08
  year: 2012
  text: August 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
– name: Edgecliff
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley-Blackwell
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley-Blackwell
– name: Wiley Subscription Services, Inc
References 2001; 166
2009; 56
2009; 55
2006; 93
1998; 160
2002; 5
1989; 141
1995; 46
2000; 55
2000; 85
2005; 138
1992; 148
1998
1999; 11
2000; 163
1997; 49
2005
2007; 51
2011; 59
2008; 102
2003; 169
2001; 57
2001; 58
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
Walsh PC (e_1_2_7_21_2) 1998
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_11_2
e_1_2_7_10_2
Niel‐Weise BS (e_1_2_7_23_2) 2005
e_1_2_7_26_2
e_1_2_7_27_2
e_1_2_7_28_2
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_22_2
e_1_2_7_20_2
References_xml – volume: 85
  start-page: 1067
  year: 2000
  end-page: 8
  article-title: Early catheter removal in 100 consecutive patients undergoing radical retropubic prostatectomy
  publication-title: BJU Int
– volume: 169
  start-page: 2289
  year: 2003
  end-page: 92
  article-title: Vattikuti Institute prostatectomy: technique
  publication-title: J Urol
– volume: 49
  start-page: 400
  year: 1997
  end-page: 3
  article-title: Urethral catheter removal prior to hospital discharge following radical prostatectomy
  publication-title: Urology
– volume: 169
  start-page: 2170
  year: 2003
  end-page: 2
  article-title: Early catheter removal after radical retropubic prostatectomy: long‐term followup
  publication-title: J Urol
– volume: 163
  start-page: 1643
  year: 2000
  end-page: 9
  article-title: Laparoscopic radical prostatectomy: the Montsouris technique
  publication-title: J Urol
– volume: 57
  start-page: 742
  year: 2001
  end-page: 6
  article-title: Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence
  publication-title: Urology
– volume: 148
  start-page: 1549
  year: 1992
  end-page: 57
  article-title: The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association
  publication-title: J Urol
– volume: 55
  start-page: 630
  year: 2000
  end-page: 4
  article-title: Laparoscopic radical prostatectomy: preliminary results
  publication-title: Urology
– volume: 163
  start-page: 865
  year: 2000
  end-page: 6
  article-title: Experience with early catheter removal after radical retropubic prostatectomy
  publication-title: J Urol
– volume: 56
  start-page: 89
  year: 2009
  end-page: 96
  article-title: Vattikuti Institute prostatectomy: technical modifications in 2009
  publication-title: Eur Urol
– volume: 93
  start-page: 1038
  year: 2006
  end-page: 44
  article-title: A meta‐analysis comparing suprapubic and transurethral catheterization for bladder drainage after abdominal surgery
  publication-title: Br J Surg
– volume: 5
  start-page: 291
  year: 2002
  end-page: 5
  article-title: Urethral catheter removal 3 days after radical retropubic prostatectomy is feasible and desirable
  publication-title: Prostate Cancer Prostatic Dis
– volume: 56
  start-page: 325
  year: 2009
  end-page: 30
  article-title: Impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy
  publication-title: Eur Urol
– volume: 141
  start-page: 79
  year: 1989
  end-page: 81
  article-title: Radiographic assessment of the vesicourethral anastomosis directing early decatheterization following nerve‐sparing radical retropubic prostatectomy
  publication-title: J Urol
– volume: 46
  start-page: 429
  year: 1995
  end-page: 31
  article-title: Early urethral catheter removal following radical prostatectomy: a pilot study
  publication-title: Urology
– volume: 56
  start-page: 331
  year: 2009
  article-title: Editorial comment on: impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy
  publication-title: Eur Urol
– volume: 51
  start-page: 648
  year: 2007
  end-page: 58
  article-title: Vattikuti Institute prostatectomy: contemporary technique and analysis of results
  publication-title: Eur Urol
– volume: 11
  start-page: 319
  year: 1999
  end-page: 26
  article-title: Development and evaluation of an abridged, 5‐item version of the International Index of Erectile Function (IIEF‐5) as a diagnostic tool for erectile dysfunction
  publication-title: Int J Impot Res
– volume: 55
  start-page: 1037
  year: 2009
  end-page: 63
  article-title: Retropubic, laparoscopic, and robot‐assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies
  publication-title: Eur Urol
– volume: 58
  start-page: 425
  year: 2001
  end-page: 9
  article-title: Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable
  publication-title: Urology
– volume: 166
  start-page: 1662
  year: 2001
  end-page: 4
  article-title: Early removal of the catheter after laparoscopic radical prostatectomy
  publication-title: J Urol
– issue: 3
  year: 2005
  article-title: Urinary catheter policies for short‐term bladder drainage in adults
  publication-title: Cochrane Database Syst Rev
– volume: 138
  start-page: 837
  year: 2005
  end-page: 43
  article-title: The NSQIP: a new frontier in surgery
  publication-title: Surgery
– volume: 160
  start-page: 2418
  year: 1998
  end-page: 24
  article-title: Anatomic radical prostatectomy: evolution of the surgical technique
  publication-title: J Urol
– volume: 59
  start-page: 684
  year: 2011
  end-page: 98
  article-title: Safety profile of robot‐assisted radical prostatectomy: a standardized report of complications in 3317 patients
  publication-title: Eur Urol
– start-page: 2565
  year: 1998
  end-page: 88
– volume: 102
  start-page: 1000
  year: 2008
  end-page: 4
  article-title: Catheter‐less robotic radical prostatectomy using a custom‐made synchronous anastomotic splint and vesical urinary diversion device: report of the initial series and perioperative outcomes
  publication-title: BJU Int
– ident: e_1_2_7_22_2
  doi: 10.1002/bjs.5424
– ident: e_1_2_7_17_2
  doi: 10.1016/S0022-5347(17)36966-5
– ident: e_1_2_7_3_2
  doi: 10.1016/j.eururo.2009.01.036
– ident: e_1_2_7_24_2
  doi: 10.1016/S0090-4295(00)01048-7
– ident: e_1_2_7_11_2
  doi: 10.1016/j.eururo.2009.04.018
– start-page: 2565
  volume-title: Campbell's Urology
  year: 1998
  ident: e_1_2_7_21_2
– ident: e_1_2_7_15_2
  doi: 10.1016/j.eururo.2009.04.032
– issue: 3
  year: 2005
  ident: e_1_2_7_23_2
  article-title: Urinary catheter policies for short‐term bladder drainage in adults
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_7_9_2
  doi: 10.1046/j.1464-410x.2000.00670.x
– ident: e_1_2_7_19_2
  doi: 10.1016/j.surg.2005.08.016
– ident: e_1_2_7_7_2
  doi: 10.1097/01.ju.0000065860.16392.19
– ident: e_1_2_7_5_2
  doi: 10.1038/sj.pcan.4500601
– ident: e_1_2_7_20_2
  doi: 10.1016/j.eururo.2011.01.045
– ident: e_1_2_7_26_2
  doi: 10.1016/S0090-4295(96)00491-8
– ident: e_1_2_7_10_2
  doi: 10.1016/S0022-5347(05)67820-2
– ident: e_1_2_7_16_2
  doi: 10.1016/j.eururo.2006.10.055
– ident: e_1_2_7_8_2
  doi: 10.1016/S0022-5347(05)65648-0
– ident: e_1_2_7_6_2
  doi: 10.1016/S0022-5347(05)67512-X
– ident: e_1_2_7_14_2
  doi: 10.1097/01.ju.0000067464.53313.dd
– ident: e_1_2_7_28_2
  doi: 10.1016/S0090-4295(01)01218-3
– ident: e_1_2_7_27_2
  doi: 10.1016/S0090-4295(99)80237-4
– ident: e_1_2_7_25_2
  doi: 10.1016/S0022-5347(17)40595-7
– ident: e_1_2_7_12_2
  doi: 10.1111/j.1464-410X.2008.07875.x
– ident: e_1_2_7_13_2
  doi: 10.1016/j.eururo.2009.04.019
– ident: e_1_2_7_4_2
  doi: 10.1016/S0090-4295(00)00502-1
– ident: e_1_2_7_18_2
  doi: 10.1038/sj.ijir.3900472
– ident: e_1_2_7_2_2
  doi: 10.1016/S0022-5347(01)62202-X
SSID ssj0014665
Score 2.2145267
Snippet Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? •  Initial reports of percutaneous suprapubic...
Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic...
Study Type - Therapy (case series) Level of Evidence4 What's known on the subject? and What does the study add? * Initial reports of percutaneous suprapubic...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 580
SubjectTerms Biological and medical sciences
Bladder
Drainage - instrumentation
Drainage - methods
Equipment Failure
Follow-Up Studies
Humans
Length of Stay
Male
Medical research
Medical sciences
Middle Aged
Mortality
Nephrology. Urinary tract diseases
Organ Size
Patient Satisfaction
Patients
Postoperative Complications - etiology
Prostatectomy - adverse effects
Prostatectomy - methods
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
PST
RARP
robotic prostatectomy
Robotics - methods
suprapubic
suprapubic tube
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the genital tract and mammary gland
Urinary Catheterization - instrumentation
Urinary Catheterization - methods
Urination Disorders - etiology
Title Long‐term follow‐up of patients undergoing percutaneous suprapubic tube drainage after robot‐assisted radical prostatectomy (RARP)
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10786.x
https://www.ncbi.nlm.nih.gov/pubmed/22177263
https://www.proquest.com/docview/1353359558
https://www.proquest.com/docview/1030080570
Volume 110
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9UwFA4yCxHE8W11HCK40EUvbd5djo9hGByRixfuLiRpM8jobemDUVcuXfob_SWetL2VDrMYxF1fJzTpOSdfmuT7EHpOJeFOZiL2jvCYQTjFiiobJ8RJaRORqV6m8-S9OFqx4zVfj-ufwl6YgR9i-uEWIqPP1yHAjW0uBjmLWZqsByZOGMgosQh4MqUi0Oi_WU5MUvBoryo5mABsny_qubSgWU91szINNJof1C4ug6NzdNt3T4e76GxbsWFVytmia-3Cfb_A-fh_an4b3RpRLD4Y3O4OulZs7qLrJ-M8_T308125Of3941fI-9iDq5XncNZVuPR4ZHJtcNi-Vp-W0HfiqqhdBzC1KLsGN11VG6jtJ4fbzhY4DyoWkPZwr2eO69KWLZQGqD-4aI5r08814SpsYDFhUqT88g2_WB4sP7y8j1aHbz--PopHzYfYwUBIxJbl3jOXB2qoLFEsYzRPHc0zUqiC5swq6W1SGMY9JcoA_kicEyanyhHDvKcP0M6m3BSPEDaygJ5Y-Iw5z9LcGcFlak3qFE8ocSRCcvt9tRsJ0YMux2c9GxgxHRpah4bWfUPrrxFKJ8tqIAW5gs3-zIUmQwIAlHEuI7S39Sk95pFGB1WSsHWaqwg9m25DBgjTOsNX0UEoDnA_l0mEHg6--LdwGHFKIijUtfeoK7-ufnW86g8f_7PlE3QDrpNhteQe2mnrrngKCK61-31s_gE6UzoY
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkQAJ8X4ESjESBzhklTh27BzLo1rKboVWXWlvlu3YFaJsojzE48SRI7-RX8I4yS5K1UOFuCWKx4rtmfE3fsyH0POEE2Z4lobOEBZSMKdQJEKHETGc6yjNREfTOT9Kp0t6uGKrgQ7I34Xp80NsF9y8ZXT-2hu4X5A-a-U0pHG06lNxQiQj0gkAyssUcIePxN4strmkoGzHK9nLAHAfH-s5t6bRXHW9VDV0m-v5Ls4DpGN8201QBzfR6aZp_bmUT5O20RPz_UzWx__U9lvoxgBk8X6vebfRJbu-g67Mh636u-jnrFif_P7xy7t-7EDbii_w1pa4cHhI5lpjf4OtOilg-sSlrUwLSNUWbY3rtqwUNPejwU2rLc49kQV4PtxRmuOq0EUDtQHw91qa40p120249HdYlN8XKT5_wy8W-4sPL--h5cHb49fTcKB9CA3EQmmoae4cNbnPDpVFgmY0yWOT5BmxwiY51YI7HVlFmUuIUABBImNSlSfCEEWdS-6jnXWxtg8RVtzCZJy6jBpH49yolPFYq9gIFiXEkADxzQBLM-RE99Qcp3IUG1HpO1r6jpZdR8uvAYq3kmWfF-QCMnsjHdoKEsCglDEeoN2NUsnBldTSE5P429NMBOjZ9jM4Ab-z04-K9FxxAP0ZjwL0oFfGv5VD0MlJmkBbO5W68O_KV4fL7vHRP0s-RVenx_OZnL07ev8YXYMypD88uYt2mqq1TwDQNXqvM9Q_0pU-Nw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLZQkSokxL4ESjESBzhklDhO7BzLMiqlraoRI83N8lqhwiTKIpYTR478Rn4Jz0kmKFUPFeKWKH5W7Lzle7H9PoSeJ4ykmuVZ6DRJQwrmFPKEqzAimjEVZTnvaDqPjrP9JT1Ypath_5M_C9PXhxh_uHnL6Py1N_DSuPNGTkMaR6u-EickMjybAZ68SjMAFh4gLcZSUtC2o5XsZQC3T3f1XNjTJFRdL2UNs-Z6uouL8OgU3nbxaX4TnW1G1m9LOZu1jZrp7-eKPv6fod9CNwYYi_d6vbuNrtj1HbR9NCzU30U_D4v16e8fv7zjxw50rfgCd22JC4eHUq419ufXqtMCgicubaVbwKm2aGtct2UlYbQfNW5aZbHxNBbg93BHaI6rQhUN9Aaw3-uowZXsFptw6U-wSL8qUnz-hl8s9hYnL--h5fzth9f74UD6EGrIhLJQUeMc1cbXhsojTnOamFgnJieW28RQxZlTkZU0dQnhEgBIpHUmTcI1kdS55D7aWhdr-xBhySyE4szlVDsaGy2zlMVKxpqnUUI0CRDbfF-hh4ronpjjk5hkRlT4iRZ-okU30eJrgOJRsuyrglxCZneiQqMgAQRK05QFaGejU2JwJLXwtCT-7HTKA_RsfAwuwK_r9F9FeKY4AP4piwL0oNfFv51DyslIlsBYO4269OuKVwfL7vLRP0s-Rdsnb-bi8N3x-8foGjQh_c7JHbTVVK19AmiuUbudmf4B3vI85g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long%E2%80%90term+follow%E2%80%90up+of+patients+undergoing+percutaneous+suprapubic+tube+drainage+after+robot%E2%80%90assisted+radical+prostatectomy+%28RARP%29&rft.jtitle=BJU+international&rft.au=Sammon%2C+Jesse+D.&rft.au=Trinh%2C+Quoc%E2%80%90Dien&rft.au=Sukumar%2C+Shyam&rft.au=Diaz%2C+Mireya&rft.date=2012-08-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=110&rft.issue=4&rft.spage=580&rft.epage=585&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10786.x&rft.externalDBID=10.1111%252Fj.1464-410X.2011.10786.x&rft.externalDocID=BJU10786
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon